Qureshi, A.I., Kirmani, J.F., Hussein, H.M., Harris-Lane, P., Divani, A.A., Suri, M.F., et al. (2006) Early and Intermediate-Term Outcomes with Drug-Eluting Stents in High-Risk Patients with Symptomatic Intracranial Stenosis. Neurosurgery, 59, 1044-1051.

has been cited by the following article:

• TITLE: Intracranial Atherosclerosis: The Natural History and Management Strategies

  AUTHORS: Ossama Mansour, Martin Schumacher, Mohammad A. Farrag, Foad Abd-Allah

  KEYWORDS: Intracranial Atherosclerosis, Medical Therapy, Endovascular Treatment

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.7, June 12, 2014

  ABSTRACT: Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.